Aller au contenu principal
Profil bibliographique

Maria Eugenia Marques da Costa

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

5Publications signalées
1Citations signalées
4Affiliations récentes

Les institutions déclarées

Les domaines associés

Mitochondrial Function and PathologyCancer, Hypoxia, and MetabolismGlioma Diagnosis and TreatmentSarcoma Diagnosis and TreatmentCell death mechanisms and regulation

Les publications récentes

2026 preprint OpenAlex

Combined inhibition of AIF/CHCHD4 interaction and GLS1 to exploit metabolic vulnerabilities in pediatric osteosarcoma

Hong-Toan Lai, Tran Ngoc Anh Nguyen, Maria Eugenia Marques da Costa, Romain Fernandes et autres

Abstract Osteosarcoma is a malignant bone tumor with a high risk of metastatic relapse and poor outcomes due to primary and acquired chemoresistance. This highlights the medical need to develop effective targeted approaches to overcome chemoresistance. Recent studies have revealed the roles …

fr (code pays fourni par la source)

0 citations bioRxiv (Cold Spring Harbor Laboratory)
2026 conference-abstract OpenAlex

Abstract 6170: Development and characterization of 3D osteosarcoma models recapitulating tumor heterogeneity and bone microenvironment

Margaux Chantoiseau, Pierre Khneisser, Birgit Geoerger, N. Gaspar et autres

Abstract Introduction: Osteosarcoma is the most common primary bone cancer in adolescents and young adults. It is characterized by high heterogeneity and a hostile bone microenvironment shaped by osteoclasts, endothelial cells, and immunosuppressive myeloid populations, underscoring the need for innovative models to …

fr (code pays fourni par la source)

0 citations Cancer Research
Accès ouvert 2026 preprint OpenAlex

The ITCC-P4 PDX platform of pediatric cancers for preclinical testing

Aniello Federico, Apurva Gopisetty, Didier Surdez, Yasmine Iddir et autres

Abstract Cancer is the leading cause of disease-related deaths among children in high-income countries. Tumor heterogeneity and lack of mechanism-of-action-based therapeutic options are key challenges to overcome in order to improve pediatric cancer patients’ survival. Here, we report the EU-IMI-2 funded public-private …

de, fr, ch, nl, gb, us, at, sg, kr, br, es, cz, au, it (code pays fourni par la source)

1 citation bioRxiv (Cold Spring Harbor Laboratory)

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.